Chronic Kidney Disease Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who have given their written agreement to take part in the study.
- Men or women aged 18 years or older.
- People who have chronic kidney disease linked to type 2 diabetes, along with higher-than-normal levels of a protein called albumin in their urine (a urine test result above 30 mg/g).
- People who have been started on a medication called finerenone in routine medical care, following the approved prescribing guidelines, within the 2 months before joining the study.
Who may not be able to join:
- People whose kidneys are functioning below a certain level, based on a measure called eGFR being lower than 25 mL/min/1.73 m² (confirm with trial site).
- People with severe liver problems.
- People who have been diagnosed with a type of heart failure where the heart pumps weakly (known as HFrEF) and who still have ongoing symptoms.
- People with a confirmed kidney disease that is not caused by diabetes, including a significant narrowing of the arteries supplying the kidneys.
- People whose blood pressure is not well controlled — specifically, a sitting systolic reading of 160 mmHg or higher, or a diastolic reading of 100 mmHg or higher, at the time of joining.
- People who are currently taking certain medications — including eplerenone, spironolactone, any renin inhibitor, or a potassium-sparing water tablet — unless those medications were stopped at least 4 weeks before joining the study.
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: (+)1-888-84 22937
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Percentage of patients who show an improvement in the Klinrisk model score after 24 months of treatment with finerenone.
Can't join this trial?
Data last synced from ClinicalTrials.gov: 23 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.